These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 335498)

  • 1. [Detection of the optimal dose of spironolactone for the treatment of benign essential hypertension].
    Rhomberg F
    Schweiz Med Wochenschr; 1977 Sep; 107(35):1228-32. PubMed ID: 335498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind comparison of spironolactone and hydrochlorothiazide in hypertensive patients treated with metoprolol.
    Lavenius B; Hansson L
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):291-5. PubMed ID: 7049966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.
    Kreeft JH; Larochelle P; Ogilvie RI
    Can Med Assoc J; 1983 Jan; 128(1):31-4. PubMed ID: 6336600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Double-blind therapeutic trial of spironolactone in arterial hypertension].
    Chávez-Domínguez R; Sánchez-Torres G; Serrano P
    Arch Inst Cardiol Mex; 1975; 45(4):487-94. PubMed ID: 1101838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive effect and serum potassium homeostasis: comparison of hydrochlorothiazide and spironolactone alone and in combination.
    Nash DT
    J Med; 1977; 8(5):367-77. PubMed ID: 338851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
    Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC
    Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and tolerability of enalapril compared to altizide combined with spironolactone in patients with moderate arterial hypertension].
    Gibelin P; Durand P; Baudouy M; Camous JP; Morand P
    Ann Cardiol Angeiol (Paris); 1986 May; 35(5):279-83. PubMed ID: 3019212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of benign essential hypertension with frusemide in different doses.
    Valmin K; Hansen T; Rønsted P
    Pharmatherapeutica; 1980; 2(5):296-304. PubMed ID: 7001489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide.
    Preston RA; Norris PM; Alonso AB; Ni P; Hanes V; Karara AH
    Menopause; 2007; 14(3 Pt 1):408-14. PubMed ID: 17224857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of medium-severe essential hypertension with beta-Aldopur under practice conditions].
    Tutsch G; Guberner G; Nitsch-Fitz R; Rheindorf H; Ziegler KT; Hitzenberger G
    Wien Med Wochenschr Suppl; 1985; 89():215-21. PubMed ID: 3859956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
    Pikilidou MI; Lasaridis AN; Sarafidis PA; Tziolas IM; Zebekakis PE; Dombros NV; Giannoulis E
    Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of benign essential hypertension with an association of spironolactone and thiabutazide: an open multicenter study in general practice (author's transl)].
    Rhomberg F; Leya A
    Schweiz Rundsch Med Prax; 1981 Dec; 70(50):2269-78. PubMed ID: 7031639
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trial of captopril (Aceten) in Indian patients with essential hypertension.
    Shah BP; Patel K; Oke VG; Raghu CN
    Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):415-20. PubMed ID: 3531033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of the efficacy of oral potassium canrenoate and spironolactone in essential arterial hypertension].
    Tosti-Croce C; Mantellini R; Fanti P; Sciarra F
    Minerva Med; 1983 Apr; 74(14-15):791-7. PubMed ID: 6339999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A; Mahgoub M; Hall M; Feely J
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.
    Mahmud A; Feely J
    Am J Hypertens; 2005 Jan; 18(1):50-5. PubMed ID: 15691617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter dose-response study of the effect of indapamide in the treatment of patients with mild to moderate hypertension.
    Capone P; Vukovich RA; Neiss ES; Bolton S; Reeves RL
    Clin Ther; 1983; 5(3):305-16. PubMed ID: 6342786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.